Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy

Näytä muut versiot (1)

Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by mutations in the survival motor neuron 1 (<i>SMN2</i>) gene. All patients have at least one copy of a paralog, <i>SMN2</i>, but a C-to-T transition in this gene results in exon 7 skipping in a majority of tra...

Bibliografiset tiedot
Päätekijät:	Winkelsas, AM, Grunseich, C, Harmison, GG, Chwalenia, K, Rinaldi, C, Hammond, SM, Johnson, K, Bowerman, M, Arya, S, Talbot, K, Wood, MJ, Fischbeck, KH
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Cell Press 2021

Samankaltaisia teoksia

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Tekijä: Audrey M. Winkelsas, et al.
Julkaistu: (2021-03-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Tekijä: Winkelsas, AM
Julkaistu: (2020)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Tekijä: Bowerman, M, et al.
Julkaistu: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Tekijä: Bowerman, M, et al.
Julkaistu: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Tekijä: Melissa Bowerman, et al.
Julkaistu: (2017-08-01)

Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients
Tekijä: Christopher Grunseich, et al.
Julkaistu: (2014-10-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
Tekijä: Yuri Yépez, et al.
Julkaistu: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Tekijä: Darija Šoltić, et al.
Julkaistu: (2020-03-01)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
Tekijä: Wood, M, et al.
Julkaistu: (2017)

SMN post-translational modifications in spinal muscular atrophy
Tekijä: Giulietta M. Riboldi, et al.
Julkaistu: (2023-02-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
Tekijä: Wishart, T, et al.
Julkaistu: (2010)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Julkaistu: (2020-04-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Tekijä: Niko Hensel, et al.
Julkaistu: (2020-02-01)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
Tekijä: Li-Kai Tsai
Julkaistu: (2012-01-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
Tekijä: A. I. Vlasenko, et al.
Julkaistu: (2024-12-01)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
Tekijä: Rademacher, S, et al.
Julkaistu: (2020)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
Tekijä: Valeria Valsecchi, et al.
Julkaistu: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
Tekijä: Chen-Hung Ting, et al.
Julkaistu: (2012-01-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
Tekijä: Tejal Aslesh, et al.
Julkaistu: (2022-01-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
Tekijä: Fabián Lombillo-Alfonso, et al.
Julkaistu: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
Tekijä: Fabián Lombillo, et al.
Julkaistu: (2019-05-01)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
Tekijä: Claribel D Wee, et al.
Julkaistu: (2014-01-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
Tekijä: Ines Tapken, et al.
Julkaistu: (2024-05-01)

Spinal muscular atrophy.
Tekijä: Talbot, K, et al.
Julkaistu: (2001)

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
Tekijä: Sebastian Rademacher, et al.
Julkaistu: (2020-11-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
Tekijä: Owen, N, et al.
Julkaistu: (2002)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Tekijä: Niba, Emma Tabe Eko, et al.
Julkaistu: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
Tekijä: Niba, Emma Tabe Eko, et al.
Julkaistu: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
Tekijä: Poh San Lai, et al.
Julkaistu: (2024-01-01)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
Tekijä: Matthew E.R. Butchbach, et al.
Julkaistu: (2007-08-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
Tekijä: W. Arnold, et al.
Julkaistu: (2016-03-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
Tekijä: Anderton Ryan, et al.
Julkaistu: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Tekijä: Amparo Garcia-Lopez, et al.
Julkaistu: (2018-05-01)

P423: SMN1 SMN2 gene-specific sequencing enhances the clinical sensitivity of spinal muscular atrophy diagnostic testing
Tekijä: Matthew Avenarius, et al.
Julkaistu: (2023-01-01)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
Tekijä: Hammond, S, et al.
Julkaistu: (2016)

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice
Tekijä: Kordala, AJ, et al.
Julkaistu: (2023)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
Tekijä: Paola Bernabò, et al.
Julkaistu: (2017-10-01)

Chapter 16 Spinal Muscular Atrophy
Tekijä: Talbot, K, et al.
Julkaistu: (2003)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
Tekijä: Leow, Damien Meng-Kiat, et al.
Julkaistu: (2024)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
Tekijä: Ilaria Signoria, et al.
Julkaistu: (2024-12-01)